IRCT20220120053770N1尚未招募3 期
Evaluation of the efficacy of low-dose (sub dissociative) ketamine with dexmedetomidine, and its comparison with morphine in controlling pain in patients with limb trauma referred to emergency department of Sina hospital
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 258
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Adult patients (older than 18 years old)
- •gave pain more than five points
- •limb trauma pain
- •obtaining the informed consent
排除标准
- •Pain score =5 Pregnancy and post-partum women Altered mental status Allergy to ketamine or fentanyl Body weight = 46 kg or = 115 Unstable vital signs: BP= 90 mmHg or = 180 mmHg , PR=150 or =50 bits/min , RR=10 or =30 History of recent head or eye trauma History of Siesure History of elevated ICP Chronic pain Renal or hepatic failure Substance or alcohol abuse Documented psychiatric disorders Opium addiction Recent use of narcotic analgesics
研究者
相似试验
进行中（未招募）
不适用
ow doses of Rituximab in Graves orbitopathyActive moderate to severe Graves OrbitopathyMedDRA version: 14.1Level: PTClassification code 10060742Term: Endocrine ophthalmopathySystem Organ Class: 10015919 - Eye disordersEUCTR2012-001980-53-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO10
已完成
不适用
Evaluation of the safety and efficacy of low dose transgenic rice containing peptides from Japanese cedar pollen allergens.JPRN-UMIN000016078The Jikei University, School of Medicine21
招募中
不适用
Evaluation of the effect of low-dose lung radiotherapy in the treatment of Covid 19Covid-19 Pneumonia.Pneumonia due to SARS-associated coronavirusJ12.81IRCT20201203049585N2Esfahan University of Medical Sciences36
尚未招募
Unknown
A randomised trial to find out the better treatment option between a combination of low dose rituximab and low dose prednisolone versus low dose prednisolone alone in inducing repeat remission in pemphigus vulgaris patients who develop disease relapseCTRI/2023/06/053496PGIMER, Chandigarh
招募中
4 期
A clinical trial to study the efficacy and safety of low dose versus standard dose emicizumab prophylaxis in haemophilia A patients.CTRI/2024/01/061593Department of Health Research, India